Invest now
Alkem Laboratories Balance Sheet Annual
BSE: 539523 | NSE: ALKEM | ISIN: INE540L01014 | Sector: Biotechnology & Drugs5,380.00 -19.00 (-0.35%)Updated : 17 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 20,872.97 | 17,691.10 | 15,574.90 | 13,756.63 |
| Accumulated Depreciation Total | -1,938.68 | -1,670.39 | -1,499.93 | -1,221.75 |
| Cash Equivalents | 77.29 | 107.35 | 0.00 | 74.21 |
| Other Liabilities Total | 856.99 | 712.18 | 636.69 | 544.15 |
| Accrued Expenses | 405.00 | 400.25 | 723.73 | 712.29 |
| Long Term Debt | 492.45 | 310.91 | 40.00 | 0.00 |
| Common Stock Total | 23.91 | 23.91 | 23.91 | 23.91 |
| Other Equity Total | 370.83 | 188.44 | 167.70 | 147.05 |
| Other Current Assets Total | 844.10 | 877.86 | 711.84 | 1,947.88 |
| Prepaid Expenses | 80.02 | 59.53 | 49.91 | 44.39 |
| Total Assets | 20,872.97 | 17,691.10 | 15,574.90 | 13,756.63 |
| Current Portof LT Debt/ Capital Leases | 92.68 | 67.68 | 15.18 | 19.20 |
| Cash | 170.62 | 196.79 | 455.07 | 199.59 |
| Total Equity | 13,820.10 | 11,984.87 | 10,312.06 | 9,045.29 |
| Long Term Investments | 2,291.95 | 1,298.83 | 405.13 | 524.87 |
| Retained Earnings( Accumulated Deficit) | 13,389.82 | 11,736.37 | 10,100.91 | 8,873.73 |
| Total Common Shares Outstanding | 11.96 | 11.96 | 11.96 | 11.96 |
| Property/ Plant/ Equipment Total- Gross | 5,167.21 | 4,533.12 | 4,056.97 | 3,735.27 |
| Tangible Book Valueper Share Common Eq | 1,078.56 | 957.40 | 822.79 | 715.32 |
| Goodwill Net | 523.64 | 423.11 | 416.74 | 413.17 |
| Total Liabilities | 7,052.87 | 5,706.23 | 5,262.84 | 4,711.34 |
| Total Debt | 2,047.16 | 1,380.90 | 1,418.41 | 1,396.68 |
| Short Term Investments | 3,813.54 | 3,473.78 | 3,347.25 | 869.36 |
| Cashand Short Term Investments | 4,061.45 | 3,777.92 | 3,802.32 | 1,143.16 |
| Total Receivables Net | 3,775.96 | 3,177.44 | 3,064.12 | 2,865.32 |
| Notes Payable/ Short Term Debt | 1,085.25 | 734.89 | 1,173.97 | 1,307.15 |
| Deferred Income Tax | 15.12 | 0.00 | - | - |
| Accounts Receivable- Trade Net | 3,004.88 | 2,507.63 | 2,285.46 | 2,234.49 |
| Property/ Plant/ Equipment Total- Net | 3,228.54 | 2,862.70 | 2,557.03 | 2,513.52 |
| Minority Interest | 528.83 | 448.76 | 402.34 | 389.71 |
| Total Current Liabilities | 4,782.70 | 3,966.96 | 3,994.55 | 3,707.15 |
| Total Inventory | 3,448.99 | 3,053.07 | 2,783.39 | 2,728.93 |
| ESOP Debt Guarantee | 35.54 | 36.15 | 19.54 | 0.60 |
| Accounts Payable | 2,244.18 | 1,937.35 | 1,748.12 | 1,165.03 |
| Other Currentliabilities Total | 955.59 | 826.79 | 333.55 | 503.48 |
| Total Long Term Debt | 869.23 | 578.33 | 229.26 | 70.33 |
| Intangibles Net | 400.64 | 114.57 | 57.58 | 79.38 |
| Other Long Term Assets Total | 1,878.10 | 1,781.79 | 1,529.58 | 1,346.23 |
| Note Receivable- Long Term | 339.58 | 264.28 | 197.26 | 149.78 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 12,210.52 | 10,945.82 | 10,411.58 | 8,729.68 |
| Capital Lease Obligations | 376.78 | 267.42 | 189.26 | 70.33 |
*All figures in crores except per share values
Alkem Laboratories Quick Links
Alkem Laboratories Dividend Alkem Laboratories Bonus Alkem Laboratories News Alkem Laboratories AGM Alkem Laboratories Rights Alkem Laboratories Splits Alkem Laboratories Board Meetings Alkem Laboratories Key Metrics Alkem Laboratories Shareholdings Alkem Laboratories Profit Loss Alkem Laboratories Cashflow Alkem Laboratories Q1 Results Alkem Laboratories Q2 Results Alkem Laboratories Q3 Results Alkem Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.